Elevance director granted 563 deferred stock units

PERU RAMIRO G reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

PERU RAMIRO G reported acquisition or exercise transactions in this Form 4 filing.

Elevance Health director Ramiro G. Peru received an award of 563 deferred stock units of common stock on May 13. These units were granted at no cash cost as board compensation, increasing his direct holdings to 9,908 shares. The units will be settled in common stock after five years from grant or when he leaves the board, unless he has elected a later payout date.

Insights

Equity compensation analyst

Director received a routine equity grant that modestly increases his stake.

Director Ramiro G. Peru was granted 563 deferred stock units of Elevance Health common stock as part of the Board of Directors Compensation Program. The grant was made at no cash cost, indicating compensation rather than an open-market purchase.

The units convert into common shares after five years from grant or when he leaves the board, unless he has elected a later date under the Board of Directors Deferred Compensation Plan. Following this award, he directly holds 9,908 shares, suggesting this is a modest, routine addition to his equity position rather than a large, directional bet.

Insider Trade Summary

Grant/Award: 563 shares

Grant/Award 1 txn

Insider PERU RAMIRO G

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	563	$0.00	$0.00

Holdings After Transaction: Common Stock — 9,908 shares (Direct)

Footnotes (2)

1. F1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.
2. F2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Key Figures

Deferred stock units granted: 563 units Grant price per unit: $0.00 per share Shares held after transaction: 9,908 shares +1 more

4 metrics

Deferred stock units granted 563 units Grant of common stock deferred units on May 13, 2026

Grant price per unit $0.00 per share Equity compensation, not an open-market purchase

Shares held after transaction 9,908 shares Total direct holdings following the grant

Vesting/payment timing 5 years or board departure Deferred units payable in stock at earlier of these events, unless later date elected

Key Terms

Deferred stock units, Board of Directors Compensation Program, Board of Directors Deferred Compensation Plan

3 terms

Deferred stock units financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Board of Directors Compensation Program financial

"Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program."

Board of Directors Deferred Compensation Plan financial

"Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Elevance Health (ELV) director Ramiro G. Peru report on this Form 4?

Director Ramiro G. Peru reported receiving 563 deferred stock units of Elevance Health common stock as board compensation. The grant increased his direct holdings to 9,908 shares, reflecting a routine equity award rather than an open-market purchase or sale.

How many Elevance Health (ELV) shares does Ramiro G. Peru hold after this transaction?

After the grant, Ramiro G. Peru holds 9,908 shares of Elevance Health common stock directly. This total includes the impact of the 563 deferred stock units awarded under the company’s Board of Directors Compensation Program on May 13.

What are the terms of the deferred stock units granted to Elevance Health (ELV) director Ramiro G. Peru?

The 563 deferred stock units are payable in Elevance Health common stock. They will be settled upon the earlier of five years from the grant date or when he leaves the board, unless he has elected a later payment date under the Board of Directors Deferred Compensation Plan.

Was cash paid for the Elevance Health (ELV) shares reported in this Form 4?

No cash was paid for these shares. The 563 units were granted at a price of $0.00 per share as part of Elevance Health’s Board of Directors Compensation Program, representing equity-based compensation rather than a market purchase.

Is this Elevance Health (ELV) Form 4 a buy or sell signal from Ramiro G. Peru?

This filing reflects an equity award, not a market buy or sell. The 563 deferred stock units were granted as board compensation, so it mainly shows how Elevance Health compensates directors rather than signaling an active trading decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PERU RAMIRO G

(Last) (First) (Middle)

220 VIRGINIA AVENUE

(Street)

INDIANAPOLIS INDIANA 46204

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elevance Health, Inc. [ ELV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		563(1)(2)	A	$0	9,908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

2. The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Remarks:

	/s/ Kathleen S. Kiefer, Attorney in fact	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)